InVivo Therapeutics’ Chief Scientific Officer to present at biomedical engineering materials roundtable: 3 points

InVivo Therapeutics’ Chief Scientific Officer Thomas Ulich, MD, is scheduled to present at the Committee Roundtable on Biomedical Engineering Materials and Applications on April 25 in Washington, D.C.

Advertisement

Here are three points:

 

1. The topic of the session is “Neuro Devices and Neuro Regeneration.”

 

2. Dr. Ulrich earned his medical degree at David Geffen School of Medicine at University of California Los Angeles. He has served in leadership roles at numerous healthcare industry companies.

 

3. BEMA is a roundtable initiative of the National Research Council of the National Academies of Science, Engineering and Medicine.

 

More articles on devices:
Integra LifeSciences Holdings shares up .17%: 4 points
Global bone grafts, substitutes market to hit $3.5B: 4 quick points
Oxford Finance, Silicon Valley Bank closed loan to Nuvectra: 4 takeaways

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.